Ablynx: companies and medicines worldwide

Loading your page…

Sources and licences

Medicine	Substance	Country	Status	Authorised
Cablivi	Caplacizumab	EU (EMA)	Authorised	2018
CABLIVI11mg/vial · Injectable	Caplacizumab	United States	Marketed	2019
CABLIVIPolvere e solvente per soluzione iniettabile	Caplacizumab	Italy	Authorised
Cablivi 10 mg, Poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie	Caplacizumab	Netherlands	Authorised	2018
CABLIVI 10 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE12,5 mg · Polvo y disolvente para solución inyectable	Caplacizumab	Spain	Marketed	2018
CABLIVI 10 mg10 mg · Pulb.+solv pt. sol. inj.	Caplacizumab	Romania	unknown

Medicine	Substance	Country	Status	Authorised
Cablivi	Caplacizumab	EU (EMA)	Authorised	2018
CABLIVI11mg/vial · Injectable	Caplacizumab	United States	Marketed	2019
CABLIVIPolvere e solvente per soluzione iniettabile	Caplacizumab	Italy	Authorised
Cablivi 10 mg, Poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie	Caplacizumab	Netherlands	Authorised	2018
CABLIVI 10 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE12,5 mg · Polvo y disolvente para solución inyectable	Caplacizumab	Spain	Marketed	2018
CABLIVI 10 mg10 mg · Pulb.+solv pt. sol. inj.	Caplacizumab	Romania	unknown

Country	Medicines	Current	Past	Companies
Spain	1	1	0	Companies All medicines
European Union (EMA)	1	1	0	Companies All medicines
Italy	1	1	0	Companies All medicines
Netherlands	1	1	0	Companies All medicines
Romania	1	0	1	Companies All medicines
United States	1	1	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 12 sources

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Ministerul Sănătății

Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions

Report an error or request removalCorrections from the company itself are welcome.

Ablynx

Group structure

Belgium2

Spain1

Medicines

Know your medicines, with the sources.

Ablynx

Group structure

Belgium2

Spain1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Sources and licences

At a glance

Other big groups

Group structure

🇧🇪Belgium2

🇪🇸Spain1

Medicines

Know your medicines, with the sources.

Group structure

🇧🇪Belgium2

🇪🇸Spain1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Sources and licences

At a glance

Belgium2

Spain1

Belgium2

Spain1